70 related articles for article (PubMed ID: 20945125)
1. Overview of human cytochrome P450 networks in chemical space.
Basith S; Choi S
Arch Pharm Res; 2010 Sep; 33(9):1289-91. PubMed ID: 20945125
[No Abstract] [Full Text] [Related]
2. Cytochrome P450 networks in chemical space.
Lee S; Kim D
Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
[TBL] [Abstract][Full Text] [Related]
3. Drug interactions with cytochrome P-450.
Mege J
Pa Med; 1998 Sep; 101(9):16-7. PubMed ID: 9782709
[No Abstract] [Full Text] [Related]
4. Cataloging the Repertoire of Nature's Blowtorch, P450.
Guengerich FP
Chem Biol; 2009 Dec; 16(12):1215-6. PubMed ID: 20064429
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and induction of human cytochrome P450 enzymes: current status.
Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
[TBL] [Abstract][Full Text] [Related]
7. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
[TBL] [Abstract][Full Text] [Related]
8. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
Crivori P; Poggesi I
Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
[TBL] [Abstract][Full Text] [Related]
9. Development of three parallel cytochrome P450 enzyme affinity detection systems coupled on-line to gradient high-performance liquid chromatography.
Kool J; van Liempd SM; van Rossum H; van Elswijk DA; Irth H; Commandeur JN; Vermeulen NP
Drug Metab Dispos; 2007 Apr; 35(4):640-8. PubMed ID: 17251308
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 metabolism and inhibition: analysis for drug discovery.
Jones BC; Middleton DS; Youdim K
Prog Med Chem; 2009; 47():239-63. PubMed ID: 19328293
[No Abstract] [Full Text] [Related]
11. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
12. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
Hengstler JG; Bolt HM
Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
[No Abstract] [Full Text] [Related]
13. Protein dynamics and imidazole binding in cytochrome P450 enzymes.
Verras A; Ortiz de Montellano PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1170-2. PubMed ID: 17073778
[TBL] [Abstract][Full Text] [Related]
14. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
15. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
[TBL] [Abstract][Full Text] [Related]
16. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
Foti RS; Wahlstrom JL
IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 enzymes.
Donaldson D
J R Soc Promot Health; 2000 Sep; 120(3):150-1. PubMed ID: 11077800
[No Abstract] [Full Text] [Related]
18. Kinetics of substrate reaction in the course of hydroperoxide-mediated inactivation of cytochrome P450 1A1.
Yu XC; Liang C; Strobel HW
Biochemistry; 1996 May; 35(20):6289-96. PubMed ID: 8639571
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate.
Kim JY; Baek M; Lee S; Kim SO; Dong MS; Kim BR; Kim DH
Drug Metab Dispos; 2001 Dec; 29(12):1555-60. PubMed ID: 11717174
[TBL] [Abstract][Full Text] [Related]
20. [P450].
Imai Y; Yoshida Y
Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1133-40. PubMed ID: 8016342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
